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No other signif!cant difference between the groups was found in the anal- 
ysis of the lipid profile, other serum parameters or smoking habits. 
In conclusion: Both high basal plasma levels of ACE, and D/D gsne pOly- 
morphism are associated with restenosls after Ca. 
inducible Nitric Oxide Synthsss Is Expressed 
Acutely In the Arterial Media Fol lowing Balloon 
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NO released by endothelial (e) NO synthase (NOS) inhibits pletetet aggrega- 
tion and leukocyte adhesion and may also influence vascular smooth muscle 
cell (VSMC) proliferation. Expression of inducible (i) NOS by macrophage 
and VSMCs may play an important and undefined role in events following 
angioplasty. 
Wo studied the effect of balloon inlury on NOS activity using immunohis- 
techemical staining and pH] labelled nitro-L-arginine (SH-L=NOARG) autore- 
diography. Pigs underwent bilateral camtid angioplasty and warn sacrificed 
at 24 hrs, 5 days, 7 days or 21 d~ys (n = 4 each group). Proliferating cell 
nuclear antigen (PCNA) expression indicated active VSMC division, eNOS 
and iNOS activities were measured using routine macrophage iNOS peptide 
and aortic endothelial cell NOS antfsara. 
Uninjured artedas exhibited ense pH]-L-NOARG binding and strong unl- 
term endothelial staining for eNOS along the whole luminal endothelium but 
no INOS activity. 24 hrs after injury endothelial denudation was complete and 
eNOS was absent at the luminal surface, marked iNOS activity was detected 
throughout the media reflecting INOS induction in VSMCs. 5 days after in- 
jury, some eNOS activity was de!actable at the lumen and iNOS activity was 
maximal in the forming neo-intimal layer. At 7 days (time of maximal intimal 
proliferation detected by PCNA) eNOS covered most of the luminal surface, 
with INOS activity only in the neointima, By 21 days (time of maximal Inti- 
real growth measured by cross sectional planimetry) [3H]-L-NOARG binding 
and eNOS staining were as in uninjured arteries. We conclude that iNOS is 
prominently expmased in the artedal media within 24 hrs of balloon injury 
NO. Release of NO by VSMCs may have an important role in the processes 
of neointima formation following balloon injury. 
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The aim of this study was to determine the occurrence of programmed cell 
death (apeptesis) in re!ation to the proliferative response in the Intlmal layer 
after experimental balloon angioplasty. After induction of an intimal plaque in 
the dght carotid artery by electrical stimulation, 26 rabbits underwent balloon 
angioplaety. Eight animals served as a control group without intervention. To 
study the time course of intimal apoptosls and sail pmliferation the vessels 
were exised 7,14 and 28 days after balloon angioplasty, For in-situ detection 
of apeptesis, the TUNEL-technique (TdT-mediated UTP-tiuoresceio nick 
end labeling) was used in order to allow the differentiation between inter- 
nucioosomai DNA-degredetion, typical for apoptosis, and the more random 
DNA destruction in necrosis. Results obtained with this molecular technique 
have been controlled by assessment of programmed cell death by moq0ho- 
logical cdteda. In addition, bromndeoxyuddine-labeling in all animals allowed 
the determlnetibn of coils undergoing DNA-synthesls in the neo-lntlmai rea 
in percent, Within 28 days after balloon angioplasty the number of cells un- 
dergoing apeptosls was not significantly different to the control group without 
interventionai treatment (controls: 0.07 4- 0.1%; 7 d: 0.18 4- 0.17%; 14 d: 
0.07 4- 0,07%; 28 d: 0,12 4- 0.06%). The number of cells undergoing DNA 
synthesis was significantly increased by day 7 after angioplasty (4.1 ± 1.5% 
vs. 0.6 4- 0.3% in controls), resulting in an intimal thickening from 02 4- 39 
/~m up to 242 4- 165/~m at 28 days following balloon dilatation, In contrast 
to an excessive increase of Inlimai proliferation, the present study indicates 
that the number of apoptutic elts remain on a very low level within 28 days 
after balloon angioplasty. Our data suggest that significant changes in the 
occurrence of apaptosls are probably not involved in the regulation of cellular 
turn-over dudng the early stage of vessel wall response after vascular injury. 
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Both neointimal formation and artedai remodeling have been implicated as 
the pathological processes msponsibl3 for post-angioplasty restenosis. The 
purpose of this study was to pmspactively study the proliferation, growth, 
end migration of SMC in etheroscfemtic and restenotib tissue obtained from 
62 consecutive Pte (48 primary and 14 restenotic lesions) undergoing direo 
lionel comnary atherectemy. SH-Thymidine labeling indexed to the amount 
of DNA was used to determine the proliferative activity of the samples with 
EM-autoradlogrephio l calization. Immunocytochemical staining using MIB- 
1 antibody (specific for the KI-67 Antigen expressed by proliferating cells) 
was used to confirm the proliferative activity of SMC. In situ SMC growth 
charectedsties were determined by quantifying explant outgrowth of SMC, 
Intrinsic migratory activity of cultured SMC was determined in a modified 
micro Boyden chamber. 
The thymtdioe labeling index was slgnWcantly higher in restenotic than 
primary specimens (273,167 :b 49,621 vs 86,593 4- 8,550 CPM/DNA, p < 
0.0001). EM autoradiography localized the majority (> 60%) of thymidine 
uptake to the nuclei of SMC with < 2% of SMC demonstrating nuclear thymi- 
dine uptake. MIB-1 staining showed a higher proliferation index in restenotic 
specimens (1.95 4- 0.4% vs 0.58:1: 0.27%, p = 0.009). SMC cultured from 
restenotic specimens had higher growth rate than cells from pdmary spec- 
imens (Slopes: 24.16 vs 12.35, p = 0.001). The intrinsic migratory activity 
was higher in SMC derived from restenotio lesions than SMC derived from 
pdmary specimens (30 4-14 vs 19 ± 0.9 cells/HPF, p :  0.02). 
In conclusion: This study damonctrates that both primary and restenotic 
atherectomy specimens how low levels of ongoing proliferation with signif- 
icantly higher proliferative activity, higher explanted SMC growth rates and 
migratory activity in roetenotic than pdmary lesions suggesting that therapies 
aimed at controlling these processes am worthy of further investigation to 
reduce restenosis. 
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Proliferation and migration of vascular smooth muscle cells (SMC) are major 
mechanisms in the pathogenesis of restenosi=. Consensus-lntertemn (clFN) 
is a new interferon-a derivative with high specific activity which has been 
implicated to regulate call proliferation and migration. In the present study 
we investigated the effects of clFN on proliferation and migration of SMC. 
Methods: SMC were cultivated from human aortic tissue. Ceils ware stim- 
ulated with 10% fetal calf samm (FCS) (n = 36) or pletelet-dedved growth 
factor-BB (PDGF-BB) (n = 12), a potent growth factor in restsnosis. SMC 
were incubated with clFN at concentrations of 0.01-10 ng/ml. Proliteration 
of cells was measured by counting cell numbers with an automated cell an- 
alyzer. Migration of SMC was determined by a modified Boyden chamber 
assay. 
Results: Proliferation of FCS-etimulated SMC was inhibited by clFN in a 
dose-dependent manner. Maximum inhibition was 56:1: 3% at a concentration 
of 10 ng/ml (p < 0,001). After withdrawal of clFN, the proliferation rate 
of cells returned to control level, suggesting a reversible mechanism of 
inhibition, Significant oxic side effects were not detected by trypan blue 
exclusion. PDGF-BB-stimuleted pmliferation of SMC was reduced by 51 
3% by clFN (p = 0.023), Immunocytochemtcal nalysis of cultivated SMC 
suggest that clFN inhibits the PDGF-BB-Induced expression of tho c-myc 
gena which has previously been demonstrated to modulate proliferation and 
migration of SMC. FCS-Induced migration of SMC was significantly inhibited 
by clFN in a dose-dependent fashion. Maximum inhibition was 48 ± 22% at 
a concentration of 10 ng/ml (p < 0.05). 
Conclusions: 1. Consensus-Interferon i hibits proliferation and migration 
of human vascular smooth muscle cells. 2. This inhibition may at least 
partially be explained by inhibition of c-myc gane expression by clFN. 3. 
CIFN treatment may be useful for the prevention of restenosis after coronary 
Interventions. 
